Their co-expression with NPM1 possibly transfers the oncogenic signal from the BCR-ABL pathways (Fig. 2) to aberrant ribosome biogenesis, affecting protein synthesis and cell growth in CML. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.